Hollencrest Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $140K | Hold |
6,500
| – | – | 0.01% | 325 |
|
2025
Q1 | $108K | Buy |
6,500
+5,000
| +333% | +$83.1K | ﹤0.01% | 353 |
|
2024
Q4 | $27.5K | Hold |
1,500
| – | – | ﹤0.01% | 587 |
|
2024
Q3 | $23.1K | Hold |
1,500
| – | – | ﹤0.01% | 641 |
|
2024
Q2 | $24.4K | Hold |
1,500
| – | – | ﹤0.01% | 606 |
|
2024
Q1 | $27.7K | Hold |
1,500
| – | – | ﹤0.01% | 581 |
|
2023
Q4 | $47K | Hold |
1,500
| – | – | ﹤0.01% | 499 |
|
2023
Q3 | $31.3K | Hold |
1,500
| – | – | ﹤0.01% | 547 |
|
2023
Q2 | $35.9K | Hold |
1,500
| – | – | ﹤0.01% | 544 |
|
2023
Q1 | $28.2K | Hold |
1,500
| – | – | ﹤0.01% | 572 |
|
2022
Q4 | $23.9K | Buy |
+1,500
| New | +$23.9K | ﹤0.01% | 577 |
|
2018
Q1 | – | Sell |
-7,985
| Closed | -$241K | – | 332 |
|
2017
Q4 | $241K | Hold |
7,985
| – | – | 0.03% | 240 |
|
2017
Q3 | $301K | Hold |
7,985
| – | – | 0.04% | 223 |
|
2017
Q2 | $222K | Sell |
7,985
-1,000
| -11% | -$27.8K | 0.03% | 254 |
|
2017
Q1 | $309K | Sell |
8,985
-600
| -6% | -$20.6K | 0.05% | 242 |
|
2016
Q4 | $277K | Sell |
9,585
-17
| -0.2% | -$491 | 0.04% | 226 |
|
2016
Q3 | $305K | Sell |
9,602
-3,000
| -24% | -$95.3K | 0.04% | 241 |
|
2016
Q2 | $409K | Buy |
12,602
+532
| +4% | +$17.3K | 0.06% | 213 |
|
2016
Q1 | $337K | Sell |
12,070
-2,000
| -14% | -$55.8K | 0.06% | 229 |
|
2015
Q4 | $501K | Buy |
14,070
+1,017
| +8% | +$36.2K | 0.09% | 189 |
|
2015
Q3 | $432K | Buy |
13,053
+207
| +2% | +$6.85K | 0.07% | 187 |
|
2015
Q2 | $538K | Sell |
12,846
-207
| -2% | -$8.67K | 0.08% | 179 |
|
2015
Q1 | $425K | Hold |
13,053
| – | – | 0.06% | 221 |
|
2014
Q4 | $414K | Sell |
13,053
-17,932
| -58% | -$569K | 0.05% | 239 |
|
2014
Q3 | $767K | Sell |
30,985
-19,000
| -38% | -$470K | 0.1% | 133 |
|
2014
Q2 | $1.13M | Sell |
49,985
-7,000
| -12% | -$158K | 0.15% | 107 |
|
2014
Q1 | $1.39M | Hold |
56,985
| – | – | 0.21% | 94 |
|
2013
Q4 | $1.42M | Buy |
+56,985
| New | +$1.42M | 0.23% | 86 |
|